细胞外囊泡在肝脏疾病中的作用及其治疗潜力。
Role of extracellular vesicles in liver diseases and their therapeutic potential.
机构信息
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States.
Université de Paris, AP-HP, Hôpital Beaujon, Service d'Hépatologie, DMU DIGEST, Centre de Référence des Maladies Vasculaires du Foie, FILFOIE, ERN RARE-LIVER, Centre de recherche sur l'inflammation, Inserm, UMR 1149, Paris, France.
出版信息
Adv Drug Deliv Rev. 2021 Aug;175:113816. doi: 10.1016/j.addr.2021.05.026. Epub 2021 Jun 2.
Abstract
More than eight hundred million people worldwide have chronic liver disease, with two million deaths per year. Recurring liver injury results in fibrogenesis, progressing towards cirrhosis, for which there doesn't exists any cure except liver transplantation. Better understanding of the mechanisms leading to cirrhosis and its complications is needed to develop effective therapies. Extracellular vesicles (EVs) are released by cells and are important for cell-to-cell communication. EVs have been reported to be involved in homeostasis maintenance, as well as in liver diseases. In this review, we present current knowledge on the role of EVs in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis, alcohol-associated liver disease, chronic viral hepatitis, primary liver cancers, acute liver injury and liver regeneration. Moreover, therapeutic strategies involving EVs as targets or as tools to treat liver diseases are summarized.
摘要
全球有超过 8 亿人患有慢性肝脏疾病，每年有 200 万人因此死亡。反复的肝损伤导致纤维化，进而发展为肝硬化，目前除了肝移植之外尚无其他治愈方法。为了开发有效的治疗方法，需要更好地了解导致肝硬化及其并发症的机制。细胞外囊泡（EVs）是由细胞释放的，对于细胞间通讯非常重要。有报道称，EVs 参与了内稳态的维持以及肝脏疾病的发生。在这篇综述中，我们介绍了 EVs 在非酒精性脂肪性肝病和非酒精性脂肪性肝炎、酒精相关性肝病、慢性病毒性肝炎、原发性肝癌、急性肝损伤和肝再生中的作用的最新知识。此外，还总结了涉及 EVs 作为治疗肝脏疾病的靶点或工具的治疗策略。
相似文献
1
Role of extracellular vesicles in liver diseases and their therapeutic potential.细胞外囊泡在肝脏疾病中的作用及其治疗潜力。
Adv Drug Deliv Rev. 2021 Aug;175:113816. doi: 10.1016/j.addr.2021.05.026. Epub 2021 Jun 2.
2
Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver Diseases.液体活检在病毒性肝炎、脂肪性肝病和酒精性肝病诊断中的应用。
Int J Mol Sci. 2020 May 25;21(10):3732. doi: 10.3390/ijms21103732.
3
Extracellular Vesicles in NAFLD/ALD: From Pathobiology to Therapy.非酒精性脂肪性肝病/酒精性肝病中外泌体：从病理生物学到治疗。
Cells. 2020 Mar 27;9(4):817. doi: 10.3390/cells9040817.
4
Extracellular vesicles in fatty liver disease and steatohepatitis: Role as biomarkers and therapeutic targets.脂肪性肝病和脂肪性肝炎中的细胞外囊泡：作为生物标志物和治疗靶点的作用。
Liver Int. 2023 Feb;43(2):292-298. doi: 10.1111/liv.15490. Epub 2022 Dec 30.
5
Extracellular vesicles in inflammation: Focus on the microRNA cargo of EVs in modulation of liver diseases.细胞外囊泡在炎症中的作用：聚焦于 EVs 中 microRNA 货物在肝脏疾病调节中的作用。
J Leukoc Biol. 2022 Jan;111(1):75-92. doi: 10.1002/JLB.3MIR0321-156R. Epub 2021 Nov 10.
6
Extracellular vesicles in liver disease and beyond.细胞外囊泡与肝脏疾病及其他疾病
World J Gastroenterol. 2018 Oct 28;24(40):4519-4526. doi: 10.3748/wjg.v24.i40.4519.
7
Extracellular Vesicles in the Development of the Non-Alcoholic Fatty Liver Disease: An Update.细胞外囊泡在非酒精性脂肪肝病发展中的作用：最新研究进展。
Biomolecules. 2020 Oct 30;10(11):1494. doi: 10.3390/biom10111494.
8
Intercellular Communication between Hepatic Cells in Liver Diseases.肝脏疾病中肝细胞间的细胞通讯。
Int J Mol Sci. 2019 May 2;20(9):2180. doi: 10.3390/ijms20092180.
9
Targeting extracellular vesicles-mediated hepatic inflammation as a therapeutic strategy in liver diseases.将细胞外囊泡介导的肝脏炎症作为肝脏疾病的治疗策略。
Liver Int. 2020 Sep;40(9):2064-2073. doi: 10.1111/liv.14579. Epub 2020 Jul 13.
10
Pathogenesis of Viral Hepatitis-Induced Chronic Liver Disease: Role of Extracellular Vesicles.病毒肝炎引起的慢性肝病的发病机制：细胞外囊泡的作用。
Front Cell Infect Microbiol. 2020 Nov 10;10:587628. doi: 10.3389/fcimb.2020.587628. eCollection 2020.
引用本文的文献
1
Human Umbilical Cord Blood Plasma-Derived Exosomal miR-410-3p Alleviates Liver Injury by Regulating the Mitochondria-Mediated Antiapoptotic Signaling.人脐带血血浆来源的外泌体miR-410-3p通过调节线粒体介导的抗凋亡信号减轻肝损伤。
MedComm (2020). 2025 Aug 24;6(9):e70339. doi: 10.1002/mco2.70339. eCollection 2025 Sep.
2
Extracellular Vesicles as Biomarkers in Chronic Hepatobiliary Diseases: An Overview of Their Interplay.细胞外囊泡作为慢性肝胆疾病的生物标志物：它们相互作用的概述
Int J Mol Sci. 2025 Jun 30;26(13):6333. doi: 10.3390/ijms26136333.
3
Extracellular Vesicle-Mediated Delivery of 20S Proteasomes Enhances Tau Degradation in Recipient Cells.细胞外囊泡介导的20S蛋白酶体递送增强受体细胞中的tau蛋白降解
J Extracell Vesicles. 2025 May;14(5):e70086. doi: 10.1002/jev2.70086.
4
Bioengineered extracellular vesicles: The path to precision medicine in liver diseases.生物工程细胞外囊泡：肝病精准医学之路。
Liver Res. 2025 Feb 20;9(1):17-28. doi: 10.1016/j.livres.2025.02.002. eCollection 2025 Mar.
5
Extracellular vesicles targeting non-parenchymal cells: the therapeutical effect on liver fibrosis.靶向非实质细胞的细胞外囊泡：对肝纤维化的治疗作用
eGastroenterology. 2024 Mar 19;2(1):e100040. doi: 10.1136/egastro-2023-100040. eCollection 2024 Jan.
6
The Role of Extracellular Vesicles in Liver Fibrosis: Friends or Foes?细胞外囊泡在肝纤维化中的作用：是友还是敌？
Biomedicines. 2024 Nov 22;12(12):2665. doi: 10.3390/biomedicines12122665.
7
A novel biomarker of COVI-19: MMP8 emerged by integrated bulk RNAseq and single-cell sequencing.一种新型的新冠病毒生物标志物：通过整合批量RNA测序和单细胞测序发现的基质金属蛋白酶8
Sci Rep. 2024 Dec 28;14(1):31086. doi: 10.1038/s41598-024-82227-8.
8
Extracellular Vesicles and Micro-RNAs in Liver Disease.肝病中的细胞外囊泡与微小RNA
Semin Liver Dis. 2025 Jun;45(2):167-179. doi: 10.1055/a-2494-2233. Epub 2024 Dec 3.
9
Promising nanotherapeutics of stem cell extracellular vesicles in liver regeneration.干细胞外泌体在肝脏再生中颇具前景的纳米治疗方法。
Regen Ther. 2024 Nov 5;26:1037-1047. doi: 10.1016/j.reth.2024.09.016. eCollection 2024 Jun.
10
Point-of-care testing for early-stage liver cancer diagnosis and personalized medicine: Biomarkers, current technologies and perspectives.用于早期肝癌诊断和个性化医疗的即时检测：生物标志物、现有技术及展望
Heliyon. 2024 Sep 25;10(19):e38444. doi: 10.1016/j.heliyon.2024.e38444. eCollection 2024 Oct 15.
本文引用的文献
1
Small Annexin V-Positive Platelet-Derived Microvesicles Affect Prognosis in Cirrhosis: A Longitudinal Study.小膜联蛋白 V 阳性血小板衍生微小囊泡影响肝硬化患者预后：一项纵向研究。
Clin Transl Gastroenterol. 2021 Apr 28;12(5):e00333. doi: 10.14309/ctg.0000000000000333.
2
Tumor cells derived-extracellular vesicles transfer miR-3129 to promote hepatocellular carcinoma metastasis by targeting TXNIP.肿瘤细胞衍生的细胞外囊泡将 miR-3129 转移至靶基因 TXNIP 以促进肝癌转移。
Dig Liver Dis. 2021 Apr;53(4):474-485. doi: 10.1016/j.dld.2021.01.003. Epub 2021 Feb 6.
3
Intestinal Epithelial Cell-Derived Extracellular Vesicles Modulate Hepatic Injury via the Gut-Liver Axis During Acute Alcohol Injury.急性酒精损伤期间，肠道上皮细胞衍生的细胞外囊泡通过肠-肝轴调节肝损伤。
Front Pharmacol. 2020 Dec 21;11:603771. doi: 10.3389/fphar.2020.603771. eCollection 2020.
4
The systemic inflammation hypothesis: Towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis.系统性炎症假说：走向肝硬化急性失代偿和多器官衰竭的新范式。
J Hepatol. 2021 Mar;74(3):670-685. doi: 10.1016/j.jhep.2020.11.048. Epub 2020 Dec 7.
5
Neutrophil-to-hepatocyte communication via LDLR-dependent miR-223-enriched extracellular vesicle transfer ameliorates nonalcoholic steatohepatitis.中性粒细胞-肝细胞通过 LDLR 依赖性 miR-223 富集的细胞外囊泡转移的通讯改善非酒精性脂肪性肝炎。
J Clin Invest. 2021 Feb 1;131(3). doi: 10.1172/JCI141513.
6
hUCB-MSC derived exosomal miR-124 promotes rat liver regeneration after partial hepatectomy via downregulating Foxg1.人脐带来源的间充质干细胞衍生的外泌体 miR-124 通过下调 Foxg1 促进大鼠肝部分切除术后的肝再生。
Life Sci. 2021 Jan 15;265:118821. doi: 10.1016/j.lfs.2020.118821. Epub 2020 Dec 1.
7
Protective Effects of Human Liver Stem Cell-Derived Extracellular Vesicles in a Mouse Model of Hepatic Ischemia-Reperfusion Injury.人肝干细胞衍生细胞外囊泡在肝缺血再灌注损伤小鼠模型中的保护作用。
Stem Cell Rev Rep. 2021 Apr;17(2):459-470. doi: 10.1007/s12015-020-10078-7. Epub 2020 Dec 2.
8
A High-Fat Diet Attenuates AMPK α1 in Adipocytes to Induce Exosome Shedding and Nonalcoholic Fatty Liver Development In Vivo.高脂肪饮食可减弱脂肪细胞中 AMPKα1 的表达，从而诱导外泌体释放并促进非酒精性脂肪肝的发生发展。
Diabetes. 2021 Feb;70(2):577-588. doi: 10.2337/db20-0146. Epub 2020 Dec 1.
9
Pathogenesis of Viral Hepatitis-Induced Chronic Liver Disease: Role of Extracellular Vesicles.病毒肝炎引起的慢性肝病的发病机制：细胞外囊泡的作用。
Front Cell Infect Microbiol. 2020 Nov 10;10:587628. doi: 10.3389/fcimb.2020.587628. eCollection 2020.
10
Endothelial p300 Promotes Portal Hypertension and Hepatic Fibrosis Through C-C Motif Chemokine Ligand 2-Mediated Angiocrine Signaling.内皮细胞 p300 通过 C-C 基序趋化因子配体 2 介导的血管生成信号促进门静脉高压和肝纤维化。
Hepatology. 2021 Jun;73(6):2468-2483. doi: 10.1002/hep.31617. Epub 2021 Apr 19.
Zotero 插件